Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

KalVista Pharmaceuticals (KALV) Non Operating Income (2016 - 2025)

Historic Non Operating Income for KalVista Pharmaceuticals (KALV) over the last 9 years, with Q2 2025 value amounting to $1.9 million.

  • KalVista Pharmaceuticals' Non Operating Income fell 4879.14% to $1.9 million in Q2 2025 from the same period last year, while for Apr 2025 it was $13.6 million, marking a year-over-year increase of 28.65%. This contributed to the annual value of $7.9 million for FY2025, which is 4244.62% down from last year.
  • As of Q2 2025, KalVista Pharmaceuticals' Non Operating Income stood at $1.9 million, which was down 4879.14% from $3.8 million recorded in Q3 2024.
  • Over the past 5 years, KalVista Pharmaceuticals' Non Operating Income peaked at $4.1 million during Q1 2024, and registered a low of $1.9 million during Q2 2025.